Latest Form 4 insider transactions

Aby J. Mathew, EVP & Chief Scientific Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.

Todd Berard, Chief Marketing Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.

Sean Werner, Chief Technology Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.

Tyler Newton, a Director of Weave Communications, Inc., received 32,502 shares of common stock on June 10, 2026.

Richard J Hendrix, a Director of Live Oak Acquisition Corp. V, received 14,000 shares of common stock on September 29, 2026.

Evan Charles Moore, a Director of Live Oak Acquisition Corp. V, received 14,000 shares of common stock on September 29, 2026.

Kurt Workman, President & CEO of Owlet, Inc., reported a transaction in 20,400 shares of common stock on October 6, 2026.

Adam J Fishman, a Director of Live Oak Acquisition Corp. V, received 14,000 shares of common stock on September 29, 2026.

Heather Tram Le, Chief Accounting Officer of Asana, Inc., received 106,838 shares of common stock on October 5, 2026.

Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on October 6, 2026.

Brandon Sim, CEO and President of Astrana Health, Inc., reported a transaction in 9,889 shares of common stock on October 6, 2026.

George Kurtz, PRESIDENT AND CEO and a Director of CrowdStrike Holdings, Inc., sold 20,000 shares of common stock on October 6, 2026.

Helen Torley, PRESIDENT AND CEO and a Director of Halozyme Therapeutics, Inc., sold 60,000 shares of common stock on October 6, 2026.

Bernadette Connaughton, a Director of Halozyme Therapeutics, Inc., received 3,796 shares of common stock on May 5, 2026.

Delano Ladd, EVP, General Counsel of Healthequity, Inc., reported a transaction in 1,080 shares of common stock on October 6, 2026.

Anthony D. Eisenberg, a Director of AParadise Acquisition Corp., received 266,188 shares of common stock on October 6, 2026.

Michael Henry Fiore, Former EVP, CCO of Healthequity, Inc., reported a transaction in 2,032 shares of common stock on October 6, 2026.

Juliette Han, a Director of AParadise Acquisition Corp., received 266,188 shares of common stock on October 6, 2026.

Michael Sepso, a Director of AParadise Acquisition Corp., received 266,188 shares of common stock on October 6, 2026.

James Gaskill Simpson, a Director of AParadise Acquisition Corp., received 266,188 shares of common stock on October 6, 2026.

Shain Noor, Chief Technology Officer of ProCap Financial, Inc., reported multiple transactions in common stock on October 7, 2026.

Kristopher E. Moldovan, EVP and CFO of Vistra Corp., sold 20,000 shares of common stock on October 7, 2026 for $165.00 per share.

Antonio Pineiro, President, International of Dave & Buster's Entertainment, Inc., reported a transaction in 1,624 shares of common stock on October 7, 2026.

Cory Hatton, Interim CFO of Dave & Buster's Entertainment, Inc., reported a transaction in 735 shares of common stock on October 7, 2026.

Les Lehner, SVP, Chief Development Officer of Dave & Buster's Entertainment, Inc., reported a transaction in 1,624 shares of common stock on October 7, 2026.

Thomas S. Lam, a Director of Astrana Health, Inc., reported a transaction in 2,624 shares of common stock on October 6, 2026.

Aldo Rosales, Chief Strategy & Revenue Ofc of Dave & Buster's Entertainment, Inc., reported a transaction in 895 shares of common stock on October 7, 2026.

Jayshree Ullal, CEO and Chairperson and a Director of Arista Networks, Inc., sold 460,374 shares of common stock on October 6, 2026.

Chantelle Yvette Breithaupt, Senior Vice President, CFO of Arista Networks, Inc., sold 1,224 shares of common stock on October 6, 2026 for $215.00 per share.

Tony Wehner, President Main Event of Dave & Buster's Entertainment, Inc., reported a transaction in 1,624 shares of common stock on October 7, 2026.